FISH & PAYK HEALTH
FISH & PAYK HEALTH operates in Diversified Metals & Mining.
FISH & PAYK HEALTH (FPLB) - Net Assets
Latest net assets as of March 2024: €1.76 Billion EUR
Based on the latest financial reports, FISH & PAYK HEALTH (FPLB) has net assets worth €1.76 Billion EUR as of March 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€2.28 Billion) and total liabilities (€522.60 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €1.76 Billion |
| % of Total Assets | 77.1% |
| Annual Growth Rate | 14.99% |
| 5-Year Change | 80.64% |
| 10-Year Change | N/A |
| Growth Volatility | 17.44 |
FISH & PAYK HEALTH - Net Assets Trend (2017–2024)
This chart illustrates how FISH & PAYK HEALTH's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for FISH & PAYK HEALTH (2017–2024)
The table below shows the annual net assets of FISH & PAYK HEALTH from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-03-31 | €1.76 Billion | +0.33% |
| 2023-03-31 | €1.75 Billion | +4.39% |
| 2022-03-31 | €1.68 Billion | +10.44% |
| 2021-03-31 | €1.52 Billion | +56.18% |
| 2020-03-31 | €973.80 Million | +6.64% |
| 2019-03-31 | €913.20 Million | +19.94% |
| 2018-03-31 | €761.40 Million | +15.08% |
| 2017-03-31 | €661.62 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to FISH & PAYK HEALTH's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 180.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €1.09 Billion | 62.25% |
| Other Components | €664.10 Million | 37.75% |
| Total Equity | €1.76 Billion | 100.00% |
FISH & PAYK HEALTH Competitors by Market Cap
The table below lists competitors of FISH & PAYK HEALTH ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BBVA - Dusseldorf Stock Exchang
DU:BOY
|
$182.11K |
|
BankInvest Europæisk Akt A
CO:BAIEUAA
|
$182.20K |
|
GERRESHEIMER - Dusseldorf Stock Exchang
DU:GXI
|
$182.35K |
|
Whatcom Capital II Corp
V:WAT-P
|
$182.56K |
|
Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund
NYSE:PTA
|
$181.93K |
|
ALTCF
PINK:ALTCF
|
$181.83K |
|
Tff Pharmaceuticals Inc
NASDAQ:TFFP
|
$181.70K |
|
Grayscale Decentralized Finance (DeFi) Fund LLC
OTCQB:DEFG
|
$181.70K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in FISH & PAYK HEALTH's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,753,400,000 to 1,759,100,000, a change of 5,700,000 (0.3%).
- Net income of 132,600,000 contributed positively to equity growth.
- Dividend payments of 145,500,000 reduced retained earnings.
- New share issuances of 3,000,000 increased equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €132.60 Million | +7.54% |
| Dividends Paid | €145.50 Million | -8.27% |
| Share Issuances | €3.00 Million | +0.17% |
| Other Changes | €15.60 Million | +0.89% |
| Total Change | €- | 0.33% |
Book Value vs Market Value Analysis
This analysis compares FISH & PAYK HEALTH's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.17x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 15.95x to 6.17x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-03-31 | €1.17 | €18.60 | x |
| 2018-03-31 | €1.33 | €18.60 | x |
| 2019-03-31 | €1.59 | €18.60 | x |
| 2020-03-31 | €1.70 | €18.60 | x |
| 2021-03-31 | €2.64 | €18.60 | x |
| 2022-03-31 | €2.91 | €18.60 | x |
| 2023-03-31 | €3.03 | €18.60 | x |
| 2024-03-31 | €3.01 | €18.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently FISH & PAYK HEALTH utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.54%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.54%
- • Asset Turnover: 0.77x
- • Equity Multiplier: 1.30x
- Recent ROE (7.54%) is below the historical average (22.71%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 25.57% | 19.45% | 0.99x | 1.33x | €102.99 Million |
| 2018 | 24.98% | 19.72% | 0.94x | 1.35x | €114.06 Million |
| 2019 | 22.91% | 19.51% | 0.89x | 1.32x | €117.88 Million |
| 2020 | 29.50% | 22.56% | 0.89x | 1.47x | €189.92 Million |
| 2021 | 34.47% | 26.91% | 0.94x | 1.36x | €372.11 Million |
| 2022 | 22.44% | 22.95% | 0.78x | 1.25x | €208.93 Million |
| 2023 | 14.28% | 15.76% | 0.72x | 1.26x | €74.96 Million |
| 2024 | 7.54% | 7.54% | 0.77x | 1.30x | €-43.31 Million |
Industry Comparison
This section compares FISH & PAYK HEALTH's net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $114,212,818,724
- Average return on equity (ROE) among peers: -9.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| FISH & PAYK HEALTH (FPLB) | €1.76 Billion | 25.57% | 0.30x | $181.99K |
| HORIBA (01H) | $204.49 Billion | 10.42% | 0.82x | $989.01K |
| Tokyu Corporation (01T) | $779.37 Billion | 3.34% | 2.35x | $99.73K |
| GUANGZHOU AUTO -H- (02G) | $122.28 Billion | 6.59% | 0.55x | $4.05K |
| MOSAIC (02M) | $10.60 Billion | 4.43% | 0.90x | $280.83K |
| MOSAIC (02M.SG) (02M) | $9.56 Billion | 10.46% | 0.82x | $247.21K |
| CHINA JO-JO DRGSTRS (04CN.SG) (04CN) | $16.67 Million | -126.83% | 4.46x | $1.55 Million |
| KRAKATAU STEEL -B- (07K) | $552.59 Million | 3.52% | 4.72x | $166.99 |
| CN MODERN DAIRY (07M) | $7.12 Billion | -10.42% | 1.50x | $1.68K |
| TOURMALINE OIL (08T) | $7.22 Billion | 4.81% | 0.41x | $381.02K |
| ASIA CASSAVA RESOUR (0ACS) | $913.15 Million | 2.86% | 1.55x | $325.03 |